FDA Panel Urges More Testing for Diabetes Drugs

NEW YORK (Associated Press) - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.
MORE ON THIS TOPIC